Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | 2C21H29Cl2N3O2.C4H4O4 |
| Molecular Weight | 968.832 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OC(=O)\C=C\C(O)=O.NC1=C(Cl)C=C(C=C1Cl)[C@@H](O)CNCCCCCCOCCC2=CC=CC=N2.NC3=C(Cl)C=C(C=C3Cl)[C@@H](O)CNCCCCCCOCCC4=CC=CC=N4
InChI
InChIKey=MZHXOYZUNRCUCP-MMSVOLSESA-N
InChI=1S/2C21H29Cl2N3O2.C4H4O4/c2*22-18-13-16(14-19(23)21(18)24)20(27)15-25-9-4-1-2-6-11-28-12-8-17-7-3-5-10-26-17;5-3(6)1-2-4(7)8/h2*3,5,7,10,13-14,20,25,27H,1-2,4,6,8-9,11-12,15,24H2;1-2H,(H,5,6)(H,7,8)/b;;2-1+/t2*20-;/m00./s1
| Molecular Formula | C21H29Cl2N3O2 |
| Molecular Weight | 426.38 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
| Molecular Formula | C4H4O4 |
| Molecular Weight | 116.0722 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Optical Activity | NONE |
Picumeterol (GR114297A) is a potent and highly selective beta2-adrenoceptor agonist with a longer duration of action than salbutamol, but shorter than salmeterol. Picumeterol is the (R)-isomer of the racemic entity GR63411B, and picumeterol has been shown to be about 40 times more potent than the (S)-isomer (GR114744A) in various in vitro pharmacological models of beta2-agonist activity. Picumeterol is of potential value in the treatment of asthma and related diseases in man following inhalation administration. In the clinical studies, the bronchodilator potencies of picumeterol and GR 63411B were similar. However, both drugs were short-acting, which is at odds with their activity in vitro. These compounds display dissociation between bronchodilator activity and protection against methacholine-induced bronchoconstriction.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Analysis of the Indacaterol-Regulated Transcriptome in Human Airway Epithelial Cells Implicates Gene Expression Changes in the Adverse and Therapeutic Effects of β2-Adrenoceptor Agonists. | 2018-07 |
|
| Picumeterol: dissociation of improvement in lung function and reduction of airways hyperresponsiveness in asthmatics. | 1997-02 |
|
| Some pharmacodynamic aspects on long-acting beta-adrenoceptor agonists. | 1996-06 |
|
| Kinetics and disposition of picumeterol in animals. | 1995-09 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:29:55 GMT 2025
by
admin
on
Mon Mar 31 18:29:55 GMT 2025
|
| Record UNII |
0SUN4UF93Y
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C48149
Created by
admin on Mon Mar 31 18:29:55 GMT 2025 , Edited by admin on Mon Mar 31 18:29:55 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
CHEMBL2110947
Created by
admin on Mon Mar 31 18:29:55 GMT 2025 , Edited by admin on Mon Mar 31 18:29:55 GMT 2025
|
PRIMARY | |||
|
C76544
Created by
admin on Mon Mar 31 18:29:55 GMT 2025 , Edited by admin on Mon Mar 31 18:29:55 GMT 2025
|
PRIMARY | |||
|
300000055521
Created by
admin on Mon Mar 31 18:29:55 GMT 2025 , Edited by admin on Mon Mar 31 18:29:55 GMT 2025
|
PRIMARY | |||
|
CC-54
Created by
admin on Mon Mar 31 18:29:55 GMT 2025 , Edited by admin on Mon Mar 31 18:29:55 GMT 2025
|
PRIMARY | |||
|
10350952
Created by
admin on Mon Mar 31 18:29:55 GMT 2025 , Edited by admin on Mon Mar 31 18:29:55 GMT 2025
|
PRIMARY | |||
|
0SUN4UF93Y
Created by
admin on Mon Mar 31 18:29:55 GMT 2025 , Edited by admin on Mon Mar 31 18:29:55 GMT 2025
|
PRIMARY | |||
|
130641-37-1
Created by
admin on Mon Mar 31 18:29:55 GMT 2025 , Edited by admin on Mon Mar 31 18:29:55 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE | |||
|
|
PARENT -> SALT/SOLVATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |